Blog
RSS FeedPosted by Michael Wonder on 29 Sep 2020
Pfizer CEO on the pressures of creating a COVID-19 vaccine: ‘what is at stake is beyond imagination'
30 September 2020 - Albert Bourla, 58, is chairman and chief executive of Pfizer, a multinational pharmaceutical company. Bourla is a ...
Posted by Michael Wonder on 24 Sep 2020
'Pharma resistance’ to battle superbugs
24 September 2020 - A group of pharmaceutical giants, biotech companies, industry peak bodies and the CSIRO have banded together ...
Posted by Michael Wonder on 16 Sep 2020
Up is down — pharmaceutical industry caution versus federal acceleration of COVID-19 vaccine approval
15 September 2020 - Nine pharmaceutical company leaders took the unprecedented step on 8 September 2020, of stating that they would ...
Posted by Michael Wonder on 30 Aug 2020
New poll shows wide support for several Trump drug pricing reforms, but not rebate changes
28 August 2020 - Voters in several battleground states overwhelmingly support several of President Trump’s recent proposals to drastically cut ...
Posted by Michael Wonder on 20 Aug 2020
Drug makers slash prices to win China's bulk-buy contracts
20 August 2020 - Drug makers have slashed prices by up to 95% to win state contracts in China's largest ...
Posted by Michael Wonder on 20 Aug 2020
Swiss data protection chief pushes back on drug pricing secrecy
20 August 2020 - A proposed change to the new health insurance law that seeks to keep drug prices under lock ...
Posted by Michael Wonder on 13 Aug 2020
For company behind coronavirus drug, sharp questions over pricing, potentially cheaper option
13 August 2020 - Gilead says it's testing remdesivir alternative amid questions from watchdog. ...
Posted by Michael Wonder on 11 Aug 2020
Trump’s call for essential drugs to be made in US threatens innovation, says trade group
11 August 2020 - The trade group for the US pharmaceutical industry has warned that President Donald Trump’s latest executive ...
Posted by Michael Wonder on 28 Jul 2020
Pfizer CEO says Trump’s executive orders overhauling U.S. drug pricing will upend the industry
28 July 2020 - Pfizer CEO Albert Bourla made his comment after the company reported better-than-expected second-quarter earnings and raised its ...
Posted by Michael Wonder on 28 Jul 2020
Pharma execs decline Trump offer for meeting on drug prices
27 July 2020 - A White House meeting with pharmaceutical executives that President Trump said would occur on Tuesday is ...
Posted by Michael Wonder on 22 Jul 2020
Coronavirus: pharmaceutical giants split on vaccine profits
22 July 2020 - Pharmaceutical companies are split on how they would price their potential COVID-19 vaccines, with some pledging ...
Posted by Michael Wonder on 20 Jul 2020
Many drug companies working on COVID-19 vaccines and treatments are lobbying harder than usual
20 July 2020 - Pharmaceutical companies racing to develop coronavirus treatments and vaccines have upped their lobbying presence in the ...
Posted by Michael Wonder on 16 Jul 2020
Deep dive into big pharma AI productivity: one study shaking the pharmaceutical industry
15 July 2020 - The pharmaceutical business is perhaps the only industry on the planet, where to get the product from ...
Posted by Michael Wonder on 13 Jul 2020
Doctors and patients anxious after pharma giant Apotex quits New Zealand
13 July 2020 - A patient advocate group says a pharmaceutical giant's decision to pull out of the New Zealand ...
Posted by Michael Wonder on 10 Jul 2020
Collaborative consultation on medicines policy closes
10 July 2020 - Over the past few months, Medicines New Zealand ran an online consultation on a discussion paper produced ...